Emergent Biosolutions, Inc. Press Releases

EBS 
$29.97
*  
0.40
1.32%
Get EBS Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading EBS now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Emergent BioSolutions to Participate in March 2015 Investor Conferences
2/20/2015 7:00:00 AM - GlobeNewswire


Emergent BioSolutions Announces Primary Endpoints Met in Pivotal Study Supporting Licensure of Building 55
2/13/2015 7:00:00 AM - GlobeNewswire


Emergent BioSolutions to Release Fourth Quarter and Full Year 2014 Financial Results and Conduct a Conference Call on March 5, 2015
2/12/2015 7:00:00 AM - GlobeNewswire


Emergent BioSolutions Announces Preliminary 2014 Financial Results and Provides 2015 Financial Outlook
1/11/2015 3:00:00 PM - GlobeNewswire


Emergent BioSolutions to Participate in January 2015 Investor Conferences
1/7/2015 7:00:00 AM - GlobeNewswire


Emergent BioSolutions Expands Biodefense Franchise; Acquires Portfolio of Broad Spectrum Antibiotics
12/17/2014 7:00:00 AM - GlobeNewswire


Evolva Sells EV-035 Series to Emergent BioSolutions
12/17/2014 1:01:00 AM - Business Wire
▲15.67 % Price Change since this news event. The Volume Ratio is 1.13.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day